This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, H. Articles by Papadopoulos, V. Search for Related Content PubMed PubMed Citation Articles by Li, H. Articles by Papadopoulos, V. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL

Peripheral-Type Benzodiazepine Receptor Function in Cholesterol Transport. Identification of a Putative Cholesterol Recognition/Interaction Amino Acid Sequence and Consensus Pattern¹

Departments of Cell Biology and Pharmacology, Georgetown University Medical Center, Washington, DC 20007

Address all correspondence and requests for reprints to: Dr. V. Papadopoulos, Department of Cell Biology, Georgetown University Medical Center, 3900 Reservoir Road, Washington, D.C. 20007. E-mail: papadopv{at}gunet.georgetown.edu

In steroid-synthesizing cells, like the MA-10 mouse tumor Leydig cells, the peripheral-type benzodiazepine receptor (PBR) is an outer mitochondrial membrane protein involved in the regulation of cholesterol transport from the outer to the inner mitochondrial membrane, the rate-determining step in steroid biosynthesis. Expression of PBR in Escherichia coli DE3 cells, which have no PBR, no cholesterol, and do not make steroids, induced the ability to take up cholesterol in a time-dependent, temperature-sensitive, and energy- independent manner. These cells took up no other steroids tested. Addition of the high affinity PBR ligand PK 11195 to cholesterol-loaded membranes, obtained from cells transfected with PBR, resulted in the release of the uptaken cholesterol. Expression in DE3 cells of mutant PBRs demonstrated that deletions in the cytoplasmic carboxy-terminus dramatically reduced the cholesterol uptake function of PBR, although it retained full capacity to bind PK 11195. Site-directed mutagenesis in the carboxy-terminal region of PBR demonstrated that bacteria expressing the mutant PBR proteins PBR(Y153S) and PBR(R156L) do not accumulate cholesterol, suggesting that amino acids Y153 and R156 are involved in the interaction of the receptor with cholesterol. Considering these results, we postulate the existence of a common cholesterol recognition/interaction amino acid consensus pattern (–L/V-(X)_1–5-Y-(X)_1–5-R/K-). Indeed, we found this amino acid consensus pattern in all proteins shown to interact with cholesterol. In conclusion, these data suggest that the expression of PBR confers the ability to take up and release, upon ligand activation, cholesterol. Considering the widespread occurrence of this protein and its tissue and cell specific subcellular localization, these results suggest a more general role of PBR in intracellular cholesterol transport and compartmentalization.

This article has been cited by other articles:

				J. Fan, M. B. Rone, and V. Papadopoulos Translocator Protein 2 Is Involved in Cholesterol Redistribution during Erythropoiesis J. Biol. Chem., October 30, 2009; 284(44): 30484 - 30497. [Abstract] [Full Text] [PDF]

				Y. Chen, T. Cai, H. Wang, Z. Li, E. Loreaux, J. B. Lingrel, and Z. Xie Regulation of Intracellular Cholesterol Distribution by Na/K-ATPase J. Biol. Chem., May 29, 2009; 284(22): 14881 - 14890. [Abstract] [Full Text] [PDF]

				B. Chini and M. Parenti G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats J. Mol. Endocrinol., May 1, 2009; 42(5): 371 - 379. [Abstract] [Full Text] [PDF]

				K. Boesze-Battaglia, A. Brown, L. Walker, D. Besack, A. Zekavat, S. Wrenn, C. Krummenacher, and B. J. Shenker Cytolethal Distending Toxin-induced Cell Cycle Arrest of Lymphocytes Is Dependent upon Recognition and Binding to Cholesterol J. Biol. Chem., April 17, 2009; 284(16): 10650 - 10658. [Abstract] [Full Text] [PDF]

				S. S.-L. Chen, P. Yang, P.-Y. Ke, H.-F. Li, W.-E. Chan, D.-K. Chang, C.-K. Chuang, Y. Tsai, and S.-C. Huang Identification of the LWYIK Motif Located in the Human Immunodeficiency Virus Type 1 Transmembrane gp41 Protein as a Distinct Determinant for Viral Infection J. Virol., January 15, 2009; 83(2): 870 - 883. [Abstract] [Full Text] [PDF]

				A. Das, M. A. Davis, and L. L. Rudel Identification of putative active site residues of ACAT enzymes J. Lipid Res., August 1, 2008; 49(8): 1770 - 1781. [Abstract] [Full Text] [PDF]

				M. Kirkham, S. J. Nixon, M. T. Howes, L. Abi-Rached, D. E. Wakeham, M. Hanzal-Bayer, C. Ferguson, M. M. Hill, M. Fernandez-Rojo, D. A. Brown, et al. Evolutionary analysis and molecular dissection of caveola biogenesis J. Cell Sci., June 15, 2008; 121(12): 2075 - 2086. [Abstract] [Full Text] [PDF]

				X.-H. Sun, D. C. Flynn, V. Castranova, L. L. Millecchia, A. R. Beardsley, and J. Liu Identification of a Novel Domain at the N Terminus of Caveolin-1 That Controls Rear Polarization of the Protein and Caveolae Formation J. Biol. Chem., March 9, 2007; 282(10): 7232 - 7241. [Abstract] [Full Text] [PDF]

				C. Hager-Braun, H. Katinger, and K. B. Tomer The HIV-Neutralizing Monoclonal Antibody 4E10 Recognizes N-Terminal Sequences on the Native Antigen. J. Immunol., June 15, 2006; 176(12): 7471 - 7481. [Abstract] [Full Text] [PDF]

				R. G. Parton, M. Hanzal-Bayer, and J. F. Hancock Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J. Cell Sci., March 1, 2006; 119(Pt 5): 787 - 796. [Abstract] [Full Text] [PDF]

				Y. Liu, Z.-X. Yao, and V. Papadopoulos Cytochrome P450 17{alpha} Hydroxylase/17,20 Lyase (CYP17) Function in Cholesterol Biosynthesis: Identification of Squalene Monooxygenase (Epoxidase) Activity Associated with CYP17 in Leydig Cells Mol. Endocrinol., July 1, 2005; 19(7): 1918 - 1931. [Abstract] [Full Text] [PDF]

				N. Jamin, J.-M. Neumann, M. A. Ostuni, T. K. N. Vu, Z.-X. Yao, S. Murail, J.-C. Robert, C. Giatzakis, V. Papadopoulos, and J.-J. Lacapere Characterization of the Cholesterol Recognition Amino Acid Consensus Sequence of the Peripheral-Type Benzodiazepine Receptor Mol. Endocrinol., March 1, 2005; 19(3): 588 - 594. [Abstract] [Full Text] [PDF]

				T. Hauet, Z.-X. Yao, H. S. Bose, C. T. Wall, Z. Han, W. Li, D. B. Hales, W. L. Miller, M. Culty, and V. Papadopoulos Peripheral-Type Benzodiazepine Receptor-Mediated Action of Steroidogenic Acute Regulatory Protein on Cholesterol Entry into Leydig Cell Mitochondria Mol. Endocrinol., February 1, 2005; 19(2): 540 - 554. [Abstract] [Full Text] [PDF]

				A. NAVARRO, B. ANAND-APTE, and M.-O. PARAT A role for caveolae in cell migration FASEB J, December 1, 2004; 18(15): 1801 - 1811. [Abstract] [Full Text] [PDF]

				T. A. Spencer, P. Wang, D. Li, J. S. Russel, D. H. Blank, J. Huuskonen, P. E. Fielding, and C. J. Fielding Benzophenone-containing cholesterol surrogates: synthesis and biological evaluation J. Lipid Res., August 1, 2004; 45(8): 1510 - 1518. [Abstract] [Full Text] [PDF]

				P. Lindemann, A. Koch, B. Degenhardt, G. Hause, B. Grimm, and V. Papadopoulos A Novel Arabidopsis thaliana Protein is a Functional Peripheral-Type Benzodiazepine Receptor Plant Cell Physiol., June 15, 2004; 45(6): 723 - 733. [Abstract] [Full Text] [PDF]

				M.-K. Chen, K. Baidoo, T. Verina, and T. R. Guilarte Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization Brain, June 1, 2004; 127(6): 1379 - 1392. [Abstract] [Full Text] [PDF]

				M. A. Ostuni, K. Marazova, G. Peranzi, B. Vidic, V. Papadopoulos, R. Ducroc, and J.-J. Lacapere Functional characterization and expression of PBR in rat gastric mucosa: stimulation of chloride secretion by PBR ligands Am J Physiol Gastrointest Liver Physiol, June 1, 2004; 286(6): G1069 - G1080. [Abstract] [Full Text] [PDF]

				C. Giatzakis and V. Papadopoulos Differential Utilization of the Promoter of Peripheral-Type Benzodiazepine Receptor by Steroidogenic Versus Nonsteroidogenic Cell Lines and the Role of Sp1 and Sp3 in the Regulation of Basal Activity Endocrinology, March 1, 2004; 145(3): 1113 - 1123. [Abstract] [Full Text] [PDF]

				E. Bribes, D. Carriere, C. Goubet, S. Galiegue, P. Casellas, and J. Simony-Lafontaine Immunohistochemical Assessment of the Peripheral Benzodiazepine Receptor in Human Tissues J. Histochem. Cytochem., January 1, 2004; 52(1): 19 - 28. [Abstract] [Full Text] [PDF]

				M. Gazouli, Z. Han, and V. Papadopoulos Identification of a Peptide Antagonist to the Peripheral-Type Benzodiazepine Receptor That Inhibits Hormone-Stimulated Leydig Cell Steroid Formation J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 627 - 632. [Abstract] [Full Text] [PDF]

				M. Culty, L. Luo, Z.-X. Yao, H. Chen, V. Papadopoulos, and B. R. Zirkin Cholesterol Transport, Peripheral Benzodiazepine Receptor, and Steroidogenesis in Aging Leydig Cells J Androl, May 1, 2002; 23(3): 439 - 447. [Abstract] [Full Text] [PDF]

				H. Li, B. Degenhardt, D. Tobin, Z.-x. Yao, K. Tasken, and V. Papadopoulos Identification, Localization, and Function in Steroidogenesis of PAP7: A Peripheral-Type Benzodiazepine Receptor- and PKA (RI{alpha})-Associated Protein Mol. Endocrinol., December 1, 2001; 15(12): 2211 - 2228. [Abstract] [Full Text] [PDF]

				D. M. Stocco Tracking the Role of a StAR in the Sky of the New Millennium Mol. Endocrinol., August 1, 2001; 15(8): 1245 - 1254. [Abstract] [Full Text] [PDF]

				H. Li, Z.-x. Yao, B. Degenhardt, G. Teper, and V. Papadopoulos Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide PNAS, January 23, 2001; (2001) 31461598. [Abstract] [Full Text]

				N. Boujrad, B. Vidic, M. Gazouli, M. Culty, and V. Papadopoulos The Peroxisome Proliferator Perfluorodecanoic Acid Inhibits the Peripheral-Type Benzodiazepine Receptor (PBR) Expression and Hormone-Stimulated Mitochondrial Cholesterol Transport and Steroid Formation in Leydig Cells Endocrinology, September 1, 2000; 141(9): 3137 - 3148. [Abstract] [Full Text] [PDF]

				A. A. Yeliseev and S. Kaplan TspO of Rhodobacter sphaeroides. A STRUCTURAL AND FUNCTIONAL MODEL FOR THE MAMMALIAN PERIPHERAL BENZODIAZEPINE RECEPTOR J. Biol. Chem., February 25, 2000; 275(8): 5657 - 5667. [Abstract] [Full Text] [PDF]

				M. Gavish, I. Bachman, R. Shoukrun, Y. Katz, L. Veenman, G. Weisinger, and A. Weizman Enigma of the Peripheral Benzodiazepine Receptor Pharmacol. Rev., December 1, 1999; 51(4): 629 - 650. [Abstract] [Full Text] [PDF]

				M. Hardwick, D. Fertikh, M. Culty, H. Li, B. Vidic, and V. Papadopoulos Peripheral-Type Benzodiazepine Receptor (PBR) in Human Breast Cancer: Correlation of Breast Cancer Cell Aggressive Phenotype with PBR Expression, Nuclear Localization, and PBR-mediated Cell Proliferation and Nuclear Transport of Cholesterol Cancer Res., February 1, 1999; 59(4): 831 - 842. [Abstract] [Full Text] [PDF]

				H. Li, Z.-x. Yao, B. Degenhardt, G. Teper, and V. Papadopoulos Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide PNAS, January 30, 2001; 98(3): 1267 - 1272. [Abstract] [Full Text] [PDF]